Michigan State University psychologists say your choice of birth control could affect your Binge Eating Disorder. In a prospective cohort study published recently in the journal JAMA Network Open, doctors explain how they linked the monophasic combined oral contraceptives to emotional eating and binge eating. The good news is that the monophasic combined oestrogen and […]
The post Bulletin: Struggling with Binge Eating? Check Your Birth Control appeared first on Medical News Bulletin.
Initially, medical devices were very simple machines that collected information about the condition of the human body and displayed relevant indicators. All interpretations of such results were made by physicians With Artificial Intelligence, all these features have undergone changes. Modern medicine is becoming more interconnected and intelligent. In addition to the simple collection of data, […]
The post How AI Medical Devices Are Moving From Consumer Health to Clinical Infrastructure appeared first on Medical News Bulletin.
The pain in the shoulder can be attributed to sleeping in an awkward position, overexertion, or as a consequence of aging. But, if it does not go away, it may indicate joint damage that will get worse over time if not treated. Patients researching an orthopedic shoulder surgeon in Knoxville should learn about shoulder problems, […]
The post Why Shoulder Pain Should Never Be Ignored: Early Warning Signs of Serious Joint Damage appeared first on Medical News Bulletin.
PHOENIX — Prescribing Qlosi eye drops for presbyopia was not associated with a reduction in optical purchases or other practice performance metrics, according to a study presented here.
“The questions that kept coming up among our physicians were straightforward: Is this going to hurt us? Are patients going to stop buying glasses? Are we going to see fewer billable encounters?” Harmin J. Chima, OD, FAAO, vice president, professional services at West Point Optical Group, told Healio. “Those are legitimate questions, and nobody had real answers yet.”
Orasis Pharmaceuticals worked with West Point
The FDA approved an update to the labeled strength of Twirla, a weekly contraceptive patch, its manufacturer announced.
The change “is to provide a more accurate representation of the amount of levonorgestrel and ethinyl estradiol delivered (or transferred) to the user” of Twirla (levonorgestrel/ethinyl estradiol), Exeltis USA said in a press release.
The updated label will begin to appear on Twirla in September or October.
The manufactuer noted that the changed label strength is based on results from Study ATI-CL28 and is “consistent with the recommendations of the FDA draft guidance” for
PHOENIX — Retaine Ultra PF, a preservative-free lubricating eye drop, is now available.
The drop is an “economical option” intended for “rewetting and refreshing the eyes,” Jacob Shorrosh, marketing associate at OcuSoft, told Healio at Optometry’s Meeting.
“This is going to be for an aqueous-deficient patient,” Shorrosh said. “It’s not going to target any lipid deficiency, which [meibomian gland dysfunction] patients have. It’s more for patients who need that aqueous refreshment to the tear film.”
The drop comes in a 10 mL multidose bottle, and the active ingredients are polyethylene glycol 400
LAS VEGAS — Ocula360, an AI-based tool for diabetic retinopathy lesion detection, showed efficacy in detecting DR across multiple levels of severity, according to a speaker at Clinical Trials at the Summit.
While several automated DR assessment tools have been FDA approved, there are limitations in screening for disease severity, SriniVas R. Sadda, MD, of Doheny Eye Institute, said.
“In the ideal world, we would actually automatically detect all of the lesions on these ultra-widefield images, and that could potentially facilitate a quantitative and continuous scoring system for diabetic